Lepra Remains a Public Health Concern in Suriname
Despite being a fully curable disease, leprosy continues to affect people in Suriname.Each year, multiple individuals recieve a diagnosis, often at a late stage due to a lack of awareness and the social stigma surrounding the illness. World Leprosy Day,observed on Sunday,January 25,2026,serves as a reminder of the facts,the need to break down stigma,and the importance of collaborative efforts to eliminate leprosy.
Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. The disease primarily spreads through close, prolonged contact with an untreated individual. Symptoms include numb skin patches, nodules, and damage to the peripheral nerves.
The Ministry of Health in Suriname reported 27 new cases of leprosy in 2024, according to a statement released on January 20, 2026. This represents a 5% increase compared to the 26 cases reported in 2023. The majority of new cases are found in the districts of Wanica and paramaribo.
Early diagnosis and treatment with multidrug therapy (MDT) are crucial for preventing disability. MDT, provided free of charge by the world Health organization (WHO), is 100% effective in curing leprosy. However, delays in seeking treatment can lead to permanent nerve damage and physical impairments.
Stigma remains a significant barrier to early detection. Many individuals fear discrimination and social exclusion, leading them to conceal thier symptoms. The Surinamese Leprosy Foundation actively works to raise awareness and combat stigma through community outreach programs and educational initiatives. More information about their work can be found at https://www.leprastichting.sr/.
The WHO’s “Global Leprosy Strategy 2021-2030” aims to achieve zero leprosy cases, zero disability, and zero stigma. Success requires sustained political commitment, increased funding, and collaborative efforts from governments, healthcare providers, and civil society organizations.
